US case analysis: Myriad at the Supreme Court

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

US case analysis: Myriad at the Supreme Court

Managing IP Correspondent
August 31 2013

The subject of gene patentability is one of the most controversial topics in life sciences. In June 2013, the US Supreme Court reached a unanimous decision in the Association for Molecular Pathology v Myriad Genetics. It stated that companies cannot patent parts of naturally occurring human genes. Managing IP sat down with Fitzpatrick Cella Harper & Scinto attorneys Robert Fischer, John Carlin and Joshua Rothman to discuss the ruling

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

FeaturesMIP Special FocusLife Sciences 2013 (August 2013)
managing-ip.png
Managing IP Correspondent
Contact
more from across site and SHARED ros bottom lb

More from across our site

Trademarks
Domain names.jpeg
Weekly take: UDRP ruling shows why small businesses must fight unfair claims
A UDRP decision that found in favour of a small business in a domain name dispute could encourage more businesses to take a stand in ‘David v Goliath’ cases
Sukanya Sarkar, June 25 2025
Trademarks
UK Supreme Court
Practitioners ‘surprised’ by UK Supreme Court’s CoA rebuke
In Iconix v Dream Pairs, the Supreme Court said the Court of Appeal was wrong to interfere with an earlier ruling, prompting questions about the appeal court’s remit
Max Walters, June 25 2025
Patents
Chris Moore - formal.png
Behind the case: A ‘privilege’ to appear before EPO’s Enlarged Board of Appeal
Chris Moore at HGF reflects on the ‘spirit of collegiality’ that led to an important ruling in G1/24, a case concerning how European patent claims should be interpreted
James Nurton, June 24 2025
Trademarks
The UK Supreme Court
UK Supreme Court backs Bird & Bird client in trademark battle
The court ruled against the owner of the ‘Umbro’ mark, despite noting that post-sale confusion can be a legitimate ground for infringement
Max Walters, June 24 2025
Trademarks
Shem Otanga - CDH Kenya.jpg
Five minutes with…Shem Otanga, CDH
Shem Otanga discusses the importance of curiosity and passion, and why he would have loved to have been a professional recording artist
June 23 2025
Trademarks
Tiktok.jpg
Indian practitioners question unfair ‘TikTok’ TM decision
Practitioners say the Bombay High Court shouldn’t have refused well-known trademark recognition for TikTok simply because the app is banned in India
Sukanya Sarkar, June 23 2025
What Corporates Want
Copy of What Corporates Want 2025 (1200 x 800 px) (1).png
Brazilian law firms urged to improve risk management advice
In-house counsel explain why firms should provide risk management advice that helps them achieve their goals
Rani Mehta, June 20 2025
Copyright
Technology meets humanity background, modern remake of The Creat
Liability and fatigue: counsel predict AI trends
Attorneys at four firms explain the AI trends they expect in the future, including a potential shift in who plaintiffs sue for copyright infringement
Rani Mehta, June 20 2025
Trademarks
Dryrobe.png
Addleshaw Goddard and Lewis Silkin brace for ‘Dryrobe’ battle
The dispute at the Intellectual Property Enterprise Court pits Dryrobe against D-Robe and will include a ‘genericide’ element
Max Walters, June 20 2025
Patents
apple.jpg
This week on MIP: EBoA rules on claim construction | Apple’s $300m redemption
Novo Nordisk losing patent rights covering Ozempic in Canada and a US Supreme Court decision favouring Ed Sheeran were also among the top talking points
Sukanya Sarkar, June 20 2025
Gift this article